Literature DB >> 17060974

HIV evolution and escape.

Douglas D Richman1, Susan J Little, Davey M Smith, Terri Wrin, Christos Petropoulos, Joseph K Wong.   

Abstract

Human immunodeficiency virus (HIV) exemplifies the principles of Darwinian evolution with a telescoped chronology. Because of its high mutation rate and remarkably high rates of replication, evolution can be appreciated over periods of days in contrast to the durations conceived of by Darwin. Certain selective pressures that drive the evolution of HIV include chemotherapy, anatomic compartmentalization and the immune response. Examples of these selective forces on HIV evolution are described.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 17060974      PMCID: PMC2263778     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  46 in total

1.  The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.

Authors:  N Srinivasakumar; N Chazal; C Helga-Maria; S Prasad; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Influenza: the new acquayantance.

Authors:  T FRANCIS
Journal:  Ann Intern Med       Date:  1953-08       Impact factor: 25.391

3.  The implications of drug resistance for strategies of combination antiviral chemotherapy.

Authors:  D D Richman
Journal:  Antiviral Res       Date:  1996-01       Impact factor: 5.970

Review 4.  The global impact of HIV/AIDS.

Authors:  P Piot; M Bartos; P D Ghys; N Walker; B Schwartländer
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

5.  HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic disease.

Authors:  S Pang; H V Vinters; T Akashi; W A O'Brien; I S Chen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

6.  Rates of spontaneous mutation among RNA viruses.

Authors:  J W Drake
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

7.  Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1.

Authors:  M Poss; A G Rodrigo; J J Gosink; G H Learn; D de Vange Panteleeff; H L Martin; J Bwayo; J K Kreiss; J Overbaugh
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

8.  Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples.

Authors:  G Venturi; M Catucci; L Romano; P Corsi; F Leoncini; P E Valensin; M Zazzi
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

9.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies.

Authors:  L G Epstein; C Kuiken; B M Blumberg; S Hartman; L R Sharer; M Clement; J Goudsmit
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

View more
  17 in total

1.  Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity.

Authors:  Matthew M Cousins; San-San Ou; Maria J Wawer; Supriya Munshaw; David Swan; Craig A Magaret; Caroline E Mullis; David Serwadda; Stephen F Porcella; Ronald H Gray; Thomas C Quinn; Deborah Donnell; Susan H Eshleman; Andrew D Redd
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

2.  High-throughput identification of genetic interactions in HIV-1.

Authors:  Daniel M Weinreich
Journal:  Nat Genet       Date:  2011-05       Impact factor: 38.330

3.  Epistasis and entrenchment of drug resistance in HIV-1 subtype B.

Authors:  Avik Biswas; Allan Haldane; Eddy Arnold; Ronald M Levy
Journal:  Elife       Date:  2019-10-08       Impact factor: 8.140

4.  Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children.

Authors:  Maria M James; Lei Wang; Deborah Donnell; Matthew M Cousins; Linda Barlow-Mosha; Jessica M Fogel; William I Towler; Allison L Agwu; Danstan Bagenda; Micheal Mubiru; Philippa Musoke; Susan H Eshleman
Journal:  Pediatr Infect Dis J       Date:  2012-11       Impact factor: 2.129

5.  Estimating selection pressures on HIV-1 using phylogenetic likelihood models.

Authors:  S L Kosakovsky Pond; A F Y Poon; S Zárate; D M Smith; S J Little; S K Pillai; R J Ellis; J K Wong; A J Leigh Brown; D D Richman; S D W Frost
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

Review 6.  HIV-1 Nef in macrophage-mediated disease pathogenesis.

Authors:  Susanna L Lamers; Gary B Fogel; Elyse J Singer; Marco Salemi; David J Nolan; Leanne C Huysentruyt; Michael S McGrath
Journal:  Int Rev Immunol       Date:  2012-12       Impact factor: 5.311

7.  Genetic characterization of hepatitis B virus in peripheral blood leukocytes: evidence for selection and compartmentalization of viral variants with the immune escape G145R mutation.

Authors:  Sibnarayan Datta; Rajesh Panigrahi; Avik Biswas; Partha K Chandra; Arup Banerjee; Pradip K Mahapatra; Chinmoy K Panda; Shekhar Chakrabarti; Sujit K Bhattacharya; Kuntal Biswas; Runu Chakravarty
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

8.  Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopes.

Authors:  Simon Hoffenberg; Rebecca Powell; Alexei Carpov; Denise Wagner; Aaron Wilson; Sergei Kosakovsky Pond; Ross Lindsay; Heather Arendt; Joanne Destefano; Sanjay Phogat; Pascal Poignard; Steven P Fling; Melissa Simek; Celia Labranche; David Montefiori; Terri Wrin; Pham Phung; Dennis Burton; Wayne Koff; C Richter King; Christopher L Parks; Michael J Caulfield
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

Review 9.  Catalytic antibodies to HIV: physiological role and potential clinical utility.

Authors:  Stephanie Planque; Yasuhiro Nishiyama; Hiroaki Taguchi; Maria Salas; Carl Hanson; Sudhir Paul
Journal:  Autoimmun Rev       Date:  2008-04-29       Impact factor: 9.754

10.  Dynamic features of the selective pressure on the human immunodeficiency virus type 1 (HIV-1) gp120 CD4-binding site in a group of long term non progressor (LTNP) subjects.

Authors:  Filippo Canducci; Maria Chiara Marinozzi; Michela Sampaolo; Stefano Berrè; Patrizia Bagnarelli; Massimo Degano; Giulia Gallotta; Benedetta Mazzi; Philippe Lemey; Roberto Burioni; Massimo Clementi
Journal:  Retrovirology       Date:  2009-01-15       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.